Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Massimo Martino, Anna Grazia Recchia, Giuseppe Console, Massimo Gentile, Michele Cimminiello, Giuseppe Alberto Gallo, Anna Ferreri, Virginia Naso, Giuseppe Irrera, Giuseppe Messina, Tiziana Moscato, Ernesto Vigna, Iolanda Donatella Vincelli & Fortunato Morabito. (2017) Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?. Expert Opinion on Orphan Drugs 5:11, pages 875-887.
Read now
Read now
Samantha Pozzi, Massimo Gentile, Stefano Sacchi, Raffaella Marcheselli, Alessandro Corso, Federica Cocito, Pellegrino Musto, Attilio Guarini, Carla Minoia, Iolanda Vincelli, Roberto Ria, Elena Rivolti, Giuseppe Mele, Alessia Bari, Carla Mazzone, Stefania Badiali, Luigi Marcheselli, Antonio Palumbo & Fortunato Morabito. (2017) Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study. Leukemia & Lymphoma 58:3, pages 552-559.
Read now
Read now
Annalisa Arcari, Annalisa Chiappella, Michele Spina, Luca Zanlari, Patrizia Bernuzzi, Vanessa Valenti, Monica Tani, Roberto Marasca, Maria Giuseppina Cabras, Renato Zambello, Alberto Santagostino, Fiorella Ilariucci, Giuseppe Carli, Pellegrino Musto, Paolo Savini, Dario Marino, Francesco Ghio, Massimo Gentile, Maria Christina Cox & Daniele Vallisa. (2016) Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study. Leukemia & Lymphoma 57:8, pages 1823-1830.
Read now
Read now
Articles from other publishers (7)
Bruno Almeida Costa, Tarek H. Mouhieddine, Ricardo J. Ortiz & Joshua Richter. (2023) Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives. Critical Reviews in Oncology/Hematology 187, pages 104040.
Crossref
Crossref
Francesca Gay, Andreas Günther, Massimo Offidani, Monika Engelhardt, Marco Salvini, Vittorio Montefusco, Francesca Patriarca, Sara Aquino, Wolfram Pönisch, Stefano Spada, Natalie Schub, Silvia Gentili, Ralph Wäsch, Paolo Corradini, Christian Straka, Antonio Palumbo, Hermann Einsele, Mario Boccadoro, Pieter Sonneveld & Martin Gramatzki. (2021) Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network. Cancer 127:18, pages 3413-3421.
Crossref
Crossref
Grace Lassiter, Cole Bergeron, Ryan Guedry, Julia Cucarola, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath & Ivan Urits. (2021) Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Current Oncology 28:1, pages 640-660.
Crossref
Crossref
Leonard Naymagon & Maher Abdul-Hay. (2016) Novel agents in the treatment of multiple myeloma: a review about the future. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
D J Green, W I Bensinger, L A Holmberg, T Gooley, B G Till, L E Budde, J M Pagel, S L Frayo, J E Roden, L Hedin, O W Press & A K Gopal. (2016) Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma. Bone Marrow Transplantation 51:10, pages 1330-1336.
Crossref
Crossref
M Martino, G Tripepi, G Messina, I D Vincelli, G Console, A G Recchia, M Gentile, S Molica & F Morabito. (2016) A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy. Bone Marrow Transplantation 51:9, pages 1197-1203.
Crossref
Crossref
Edyta Subocz & Janusz Hałka. (2015) Analiza leczenia nawrotowych i opornych postaci szpiczaka plazmocytowego wśród polskich pacjentów. Acta Haematologica Polonica 46:5, pages 385-392.
Crossref
Crossref